Biotech's Relationship with the FDA: Signs of Strain but Not a Breaking Point in 2026 on February 11, 2026 Changing Drug Approval Leadership regulatory uncertainty United States Food and Drug Administration vaccine standards +
Getting to Yes: How Deal-Making Fuels Biotech Growth – 2025 Updates on September 25, 2025 acquisitions BATNA biotech dealmaking Licensing mergers patent cliffs pharmaceutical negotiations pipeline gaps regulatory uncertainty reputation valuation venture capital +
DTC vs. DTP: Regulatory Uncertainty & Access Challenges Drive New Go-to-Market Models (2025 Update) on July 29, 2025 Access Diphtheria-Tetanus-Pertussis Vaccine direct-to-consumer direct-to-patient Ditiocarb go-to-market models pharmaceutical marketing regulatory uncertainty United States Food and Drug Administration +
ASCO25 Primer: Navigating Cancer R&D Amid Regulatory Uncertainty on May 19, 2025 ASCO25 Cancer Research Changing diagnostics expert Immunotherapy Neoplasms perspectives Policy Precision Medicine regulatory uncertainty +
FDA Shakeup: Peter Marks' Resignation Rattles Biotech Industry on March 31, 2025 Peter Marks regulatory uncertainty resignation stocks United States Food and Drug Administration +